Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Paine

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptorP Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
Molecular Pharmacology|May 1, 1997
Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3P Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 21, 2000
Can oral midazolam predict oral cyclosporine disposition?M F Paine, C L Davis, D D Shen, et al.
Clinical Pharmacology and Therapeutics|May 1, 1996
Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolismK E Thummel, D O'Shea, M F Paine, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Quantitative prediction and clinical evaluation of an unexplored herb-drug interaction mechanism in healthy volunteersB T Gufford, J T Barr, V González-Pérez, et al.
Clinical and Translational Science|May 16, 2017
Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical StudiesB T Gufford, G R Ainslie, J R White, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolismM F Paine, M Khalighi, J M Fisher, et al.
Gastroenterology|June 26, 1999
Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteersR J Fontana, K S Lown, M F Paine, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitisB C Ferslew, C K Johnston, E Tsakalozou, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
First-pass metabolism of midazolam by the human intestineM F Paine, D D Shen, K L Kunze, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptorP Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
Molecular Pharmacology|May 1, 1997
Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3P Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 21, 2000
Can oral midazolam predict oral cyclosporine disposition?M F Paine, C L Davis, D D Shen, et al.
Clinical Pharmacology and Therapeutics|May 1, 1996
Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolismK E Thummel, D O'Shea, M F Paine, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Quantitative prediction and clinical evaluation of an unexplored herb-drug interaction mechanism in healthy volunteersB T Gufford, J T Barr, V González-Pérez, et al.
Clinical and Translational Science|May 16, 2017
Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical StudiesB T Gufford, G R Ainslie, J R White, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolismM F Paine, M Khalighi, J M Fisher, et al.
Gastroenterology|June 26, 1999
Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteersR J Fontana, K S Lown, M F Paine, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitisB C Ferslew, C K Johnston, E Tsakalozou, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
First-pass metabolism of midazolam by the human intestineM F Paine, D D Shen, K L Kunze, et al.
Pageof 3